Weiss Multi-Strategy Advisers’s BioNTech BNTX Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-10,618	Closed	-$1.59M	–	629
2022 Q4	$1.59M	Buy	10,618 +2,075	+24%	+$319K	0.05%	413
2022 Q3	$1.15M	Buy	8,543 +5,451	+176%	+$833K	0.03%	480
2022 Q2	$461K	Buy	+3,092	New	+$472K	0.01%	553
2020 Q4	–	Sell	-25,724	Closed	-$1.78M	–	681
2020 Q3	$1.78M	Buy	25,724 +18,188	+241%	+$1.3M	0.05%	364
2020 Q2	$503K	Buy	+7,536	New	+$376K	0.01%	466

Other funds holding BNTX

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

AGA

Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

Weiss Multi-Strategy Advisers's BNTX Position: Q1 2023 in Review

Weiss Multi-Strategy Advisers sold out of BioNTech (BNTX) in Q1 2023, closing a stake of 10,618 shares — an estimated $1.59M sold.

Weiss Multi-Strategy Advisers first reported a position in BNTX in Q2 2020 and held it in 5 quarters. The position peaked at $1.78M in Q3 2020. 282 funds tracked by Wall St. Rank hold BNTX as of Q1 2023.

Weiss Multi-Strategy Advisers reported no remaining BioNTech position as of Q1 2023 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 10,618 BioNTech shares in Q1 2023, an estimated $1.59M.
Weiss Multi-Strategy Advisers first reported a position in BioNTech in Q2 2020 and held it in 5 quarters.
Weiss Multi-Strategy Advisers's BioNTech position peaked at $1.78M in Q3 2020.
282 funds tracked by Wall St. Rank held BioNTech as of Q1 2023.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2023, filed 15 May 2023.